Business · 16/06/2025Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for Belantamab Mafodotin BLA 761440
Summary
The FDA is hosting a public meeting of the Oncologic Drugs Advisory Committee to discuss the biologic license application for Belantamab Mafodotin, and is seeking public comments on the matter.